Found 18 matching trials
Saroglitazar Magnesium for the Treatment of Nonalcoholic Steatohepatitis With Fibrosis
PHASE2Saroglitazar Magnesium for the Treatment of Nonalcoholic Steatohepatitis...
A Study to Evaluate the Effect of Saroglitazar Magnesium on the QTc Interval in Healthy Volunteers
PHASE1A Single-center, Randomized, Blinded, Placebo- and Active-controlled Crosso...
Location
Cliantha Research Limited
Safety, Tolerability, and Efficacy of Saroglitazar Mg 4 mg in Liver Transplant Recipients With Nonalcoholic Fatty Liver Disease (NAFLD)
PHASE2This is a phase 2A, single center, open-label, single-arm, 24-week study to...
Location
Virginia Commonwealth University
Saroglitazar Magnesium 4 mg for Nonalcoholic Fatty Liver Disease (NAFLD) in People Living With HIV in the US
PHASE2Saroglitazar Magnesium 4 mg for NAFLD in People Living with HIV in the US...
Saroglitazar Magnesium for Treatment of Primary Biliary Cholangitis
PHASE2Saroglitazar Magnesium 1 mg and 2 mg tablets for treatment of subjects with...
Long-Term Study to Evaluate the Safety and Efficacy in Participants With Primary Biliary Cholangitis of Saroglitazar Magnesium-V on Clinical Outcomes
PHASE3Long-Term Study to Evaluate the Safety and Efficacy in Participants with Pr...
Saroglitazar Magnesium in Patients With Nonalcoholic Fatty Liver Disease and/or Nonalcoholic Steatohepatitis
PHASE2This is a randomized, double-blind, placebo-controlled study in up to 104 p...
Location
Precision Research
Hepatic Impairment With Cirrhosis Due to Cholestatic Liver Disease
PHASE1A Phase 1, Open-label Extension Groups Study in Subjects having Hepatic Imp...
Evaluate PK & Safety of Saroglitazar in Subjects With Moderate Hepatic Impairment Due to Cholestatic Liver Disease
PHASE1Evaluating Pharmacokinetic and safety of Saroglitazar Magnesium 1 mg when d...
Study to Evaluate Absorption, Metabolism and Excretion of Single-dose [14C]-Saroglitazar in Healthy Male Subjects
PHASE1This will be a Phase I, open-label, nonrandomized, single-dose study in hea...
Location
Covance Clinical Research Unit Inc.